India Patent Cases
2,823 decisions indexed
Page 47 of 95 · 2,823 total
Sugen, Inc. v.Mr. K Vijaya Prakash
Sugen, Inc. filed applications alleging that Mr. K Vijaya Prakash and associated defendants willfully violated an injunction order passed by the Delhi High Court in 2016. The original suit concerned the infringement of three patents covering the drug Crizotinib (marketed as Xalkori®). Plaintiffs presented evidence, including photographs and investigator reports, suggesting the manufacturing and sale of the generic product 'CRIZO SPL™' after the injunction was issued. The court found that Defendant No. 1 had control over the infringing entities, leading to a finding of wilful contempt against him.
Tri-Parulex Fire Protection System v.Ctr Manufacturing Industries Private Limited
This commercial appeal challenged an interim order that restrained Tri-Parulex (appellant) from infringing the Plaintiff's Patent No. 202302, which relates to a fire protection system for electrical transformers. The Bombay High Court allowed the appeal, finding no prima facie case of infringement and noting that the balance of convenience tilted in favor of the appellant.
Microsoft Technology Licensing, Llc v.The Assistant Controller Of Patents And Designs
The petitioner challenged the position taken by the Assistant Controller of Patents and Designs. The Court found the affidavit filed by the Respondent to be inadequate in reasoning regarding Section 3(k) of the Patents Act, 1970. Consequently, the court directed the Controller General to ensure specialized Controllers assist the court on the next hearing date.
F.Hoffmann-La Roche Ltd v.Mylan Laboratories Limited
F.Hoffmann-La Roche Ltd filed a petition seeking the revocation of Patent No. 205706 held by Mylan Laboratories Limited and the Controller of Patents. However, the court noted that the term of Patent No. 205706 had already expired on June 4, 2021.
Ranbaxy Laboratories Ltd. v.Novartis AG
Ranbaxy Laboratories Ltd. filed a petition seeking the revocation of Patent No. 212815 titled “N-substituted 2-cyanopyrrolidines” under Section 64 of the Patents Act, 1970. The court dismissed the petition as infructuous after noting that the patent term had already expired and the petitioner had previously requested withdrawal.
F.Hoffmann-La Roche Ltd v.Natco Pharma Limited
F.Hoffmann-La Roche Ltd filed a petition seeking the revocation of Patent No. 252762. The court noted that the term of this patent had already expired on February 3, 2014.
F.Hoffmann-La Roche Ltd v.Mylan Laboratories Limited
F.Hoffmann-La Roche Ltd filed a petition seeking the revocation of Patent No. 205706. However, the petitioner's counsel submitted that the term of the patent had already expired on June 4, 2021.
Abs Global, Inc. v.Cytonome/ST, LLC
Abs Global, Inc. filed a petition seeking the revocation of Patent No. 240790 granted to Cytonome/ST, LLC. However, the court noted that leave had been granted in another proceeding for the petitioner (and defendants) to withdraw the revocation proceedings. Consequently, the High Court dismissed the current petition as withdrawn.
F.Hoffmann-La Roche Ltd v.Matrix Laboratories Limited
F.Hoffmann-La Roche Ltd filed a petition seeking revocation of Patent No. 224634, which was granted to Matrix Laboratories Limited. The court noted that the term of Patent No. 224634 had expired on the date of the judgment.
Lupin Limited v.Dong-A ST Co., Ltd.
Lupin Limited filed a petition seeking the revocation of Patent No. 236862 granted to Dong-A ST Co., Ltd. However, the petitioner subsequently informed the court that they would not prosecute the matter further due to the patent's term expiring shortly.
Xiaomi Technology India Private Limited v.Union Of India
Xiaomi Technology India Private Limited challenged the constitutional validity of Section 37A of FEMA, arguing it violated fundamental rights. The dispute centered on royalty payments made by Xiaomi to foreign entities like Qualcomm for Standard Essential Patents used in its mobile phones.
Blackberry Limited v.Assistant Controller Of Patents And Designs Patent Office
Blackberry Limited appealed a refusal order issued by the Assistant Controller of Patents which held that its method claims were not patentable because they consisted of executable software instructions. The High Court set aside this refusal, citing judicial precedents, and remanded the application for fresh consideration.
Honeywell International Inc. v.The Controller General Of Patents, Designs and Trademarks
Honeywell International Inc. appealed a rejection of its patent application for a low-cost programmable HVAC controller, which was denied under Section 3(k) (computer implementational invention exclusion). The Delhi High Court found that the original order lacked adequate reasoning and deliberation from the Joint Controller, merely concurring with the Examiner's finding without providing sufficient justification. Consequently, the court set aside the impugned order and remanded the matter for fresh consideration, directing the Respondent to take into account relevant judicial precedents.
Bioviz Technologies Pvt Ltd v.Schering Corporation
Bioviz Technologies Pvt Ltd filed a petition seeking the revocation of Indian Patent No. 207233 held by Schering Corporation. The court noted that the term of the patent had already expired on March 24, 2019.
Nippon Telegraph And Telephone Corporation v.Controller Of Patents And Designs
Nippon Telegraph And Telephone Corporation appealed a decision by the Assistant Controller of Patents and Designs that refused its patent application (No. 6168/DELNP/2013) under Section 15 of the Patents Act, 1970. The High Court set aside the impugned order and remanded the matter back to the Assistant Controller for fresh consideration.
Microsoft Technology Licensing, Llc v.Assistant Controller Of Patents And Design
The appeal concerns the patentability of Computer Related Inventions (CRIs). The court heard arguments regarding the interpretation of Section 3(k) of the Patents Act, 1970. The respondent was given an opportunity to file an affidavit on whether the subject patent makes a technical contribution or effect.
Matrix Labs. Limited v.Astellas Pharma Europe Bv
Matrix Labs. Limited filed a petition seeking revocation of Indian Patent No. 234753. However, the court noted that the term of the subject patent had already expired on June 25, 2017.
T.A.S. Safraj Khan (USI Traders) v.S.A.Safiullah and The Controller of Patents
The petitioner filed a petition seeking the revocation of Patent No. 198079, which was granted to S.A.Safiullah by The Controller of Patents. However, the respondent submitted that the term of the patent had already expired, rendering the matter infructuous.
N.Solomon v.S.A.Safiullah and The Controller of Patents Patent Office
N.Solomon filed a petition seeking the revocation of Patent No. 198079, which was granted to S.A.Safiullah. The court noted that the term of the said patent had expired.
T.A.S. Safraj Khan (USI Traders) v.S.A.Safiullah and The Controller of Patents
The petitioner filed a petition seeking the revocation of Patent No. 198079, which was granted by the Controller of Patents to S.A.Safiullah. The first respondent submitted that the term of the patent had expired, rendering the matter infructuous.
G.Daniel v.S.A.Safiullah and Company
G.Daniel filed a petition seeking the revocation of Patent No. 198079 under Section 64 of the Patent Act, 1970, alleging it lacked novelty and/or inventive subject. The respondent submitted that the term of the said patent had already expired.
Arena Pharmaceuticals, Inc. v.The Assistant Controller Of Patents And Designs
Arena Pharmaceuticals filed an appeal against the Assistant Controller's order rejecting its patent application. The appellant argued that certain grounds for rejection were not addressed during the hearing notice and pointed out inconsistencies within the rejection order.
B.Kailasam Sole Proprietor of M/s.Sri Ayyappan Fine Arts v.S.A.Safiullah an Indian National, trading as Sole Proprietor in the name and style of S.A.SAFIULLAH & CO
The petitioner filed a petition seeking the revocation of Patent No. 198079, which was granted to the first respondent. The court noted that the term of the said patent had expired.
Nokia Technologies Oy v.Guangdong Oppo Mobile Telecommunications Corp Ltd & Ors.
The court addressed several counter claims filed by counterclaimants seeking the revocation of four specific Indian patents (IN 259932, IN 269929, IN 321300, and IN 300066). The order directed that the counter claims be numbered, notice issued, and written statements filed.
Immunovative Therapies Ltd. v.The Controller Of Patents
Immunovative Therapies Ltd. appealed a rejection order dated December 4, 2018, concerning its patent application for 'TH1 VACCINATION PRIMING FOR ACTIVE IMMUNOTHERAPY'. The appellant argued that the rejection based on Section 3(d) and (i) was incorrect, as the invention relates to therapeutic vaccine methods using allogeneic CD3/CD28 cross-linked Thl memory cells.
Esteve Pharmaceuticals S.A. v.Controller Of Patents And Designs
Esteve Pharmaceuticals S.A. appealed a rejection order issued by the Controller of Patents and Designs regarding its Indian Patent Application No. 1435/DELNP/2012. The application, which relates to a co-crystal formulation of Tramadol and Celecoxib, was rejected for lacking novelty and inventive step under Section 3(d) and (e).
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Indoco Remedies Limited
The dispute between Bristol-Myers Squibb Holdings Ireland and Indoco Remedies Limited regarding the validity and infringement of patent IN 247381 for Apixaban was amicably resolved through mediation. The defendant acknowledged the patent's validity until its expiry date (September 17, 2022) and confirmed discontinuing all related activities.
Bristol-Myers Squibb Holdings Ireland Unlimited Company v.Metrochem Api Private Limited
The dispute between Bristol-Myers Squibb Holdings Ireland and Metrochem Api Private Limited regarding patent infringement of Apixaban was amicably resolved through court-mediated conciliation. The parties executed a Settlement Agreement, leading to the suit being decreed in terms of that agreement.
Sanjay Mehra v.Sharad Mehra & Ors.
This suit was filed by Sanjay Mehra seeking permanent injunction against Sharad Mehra & Ors. for alleged infringement and passing off related to the 'SUPERON' trademark and associated intellectual property rights. The core dispute revolved around the division of business assets, including IP, between two groups (SM Group and SDM Group) as per a Memorandum of Family Settlement (MOFS). Although the Plaintiff argued jurisdiction over the matter, the Court ultimately found that arbitration was the intended forum for resolving disputes arising from the MOFS and Sale Deed.
Ace Technologies Corp & Ors. v.Communication Components Antenna Inc.
This appeal challenged an interim injunction granted by the Delhi High Court, which restrained Ace Technologies Corp from manufacturing and selling antennae due to alleged infringement of Patent IN240893. The respondent claimed its patent covered a novel asymmetrical beam pattern for fixed antennas used in cellular networks. While the court found no grounds to interfere with the core interim relief, it modified the financial compliance terms, allowing the respondents to deposit a bank guarantee instead of cash.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.